ACAD
ACADIA Pharmaceuticals Inc
19.70$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +844.3% | -30.4% | |
| – | – | -4.2% | -2.8% | -21.4% | -114.2% | – | +35.8% | +6.5% | -45.4% | -53.0% | -61.8% | -27.5% | +160.8% | +214.1% | +182.5% | +48.4% | +10.8% | -8.0% | +6.0% | +14.1% | -39.4% | +174.0% | +186.1% | -26.0% | |
| – | – | – | – | -44.5% | -99.7% | +0.0% | -11.6% | -28.6% | -25.8% | +0.9% | +20.8% | +195.9% | +180.8% | +150.6% | +37.5% | +36.7% | +8.0% | +0.9% | +2.6% | -24.6% | +7.2% | -2.6% | +0.9% | -22.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -30.2% | +239.7% | +181.3% | +149.1% | +37.1% | +37.4% | +11.0% | -2.7% | +59.9% | -52.8% | +1.0% | – | – | – | |
| – | -95.8% | +45.3% | +1.0% | +632.4% | -95.0% | -700.0% | – | – | -200.8% | – | -3,394.6% | – | – | -55.8% | +6.8% | -245.9% | – | – | +197.9% | -324.9% | – | -52.3% | -77.1% | -2,260.2% | |
| – | – | +367.0% | -67.1% | +74.6% | +98.3% | -79.5% | -45.7% | -81.9% | -100.0% | – | +0.0% | +20,500.0% | -70.9% | +1,089.4% | +344.0% | -91.5% | +164.5% | -47.4% | +572.0% | -85.2% | -100.0% | – | -98.7% | +796.7% | |
| – | – | -481.7% | -49.8% | -9.9% | +244.8% | +82.7% | – | -86.5% | -111.2% | – | -526.9% | +394.0% | -30.8% | – | -277.5% | – | -177.3% | +132.0% | – | -136.9% | – | -56.3% | -195.4% | +890.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +600.4% | +13.7% | +82.5% | -93.0% | +3,540.1% | -94.0% | +883.2% | +21.3% | -78.2% | -77.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -59.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +502.1% | +14.0% | -5.8% | +146.7% | +40.3% | -100.4% | – | -59.5% | +2,866.8% | +604.0% | +13.8% | +82.5% | -92.9% | +3,581.0% | -94.2% | +883.2% | +21.3% | -78.2% | -77.6% | -54.9% | +206.5% | -72.8% | +628.8% | |
| – | – | – | +7.5% | -25.0% | +280.4% | -73.5% | +177.6% | -172.9% | – | – | +127,425.0% | -190.6% | – | -19.7% | +52.6% | -253.2% | – | -18.9% | +150.2% | -230.0% | – | – | +81.5% | -205.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -33.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.